Pulmicort Turbuhaler 200

Pulmicort Turbuhaler 200 is a medicine authorised by Swissmedic under authorisation number 50192. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 March 1990 and the authorisation is valid without a time limit. ATC code R03BA02 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 50192
  • ATC R03BA02
  • Synthetic medicines
Authorisation data
Authorisation number50192
NamePulmicort Turbuhaler 200
Full namePulmicort Turbuhaler 200, Pulver zur Inhalation
Authorisation holderAstraZeneca AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeR03BA02
First authorisation26 March 1990
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Pulmicort Turbuhaler 200, Pulver zur InhalationB26 March 1990
2Pulmicort Turbuhaler 100, Pulver zur InhalationB28 May 1992
3Pulmicort Turbuhaler 400, Pulver zur InhalationB28 June 1991

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
16200Einzeldose(n)R03BA0203.04.4.B
32200Einzeldose(n)R03BA0203.04.4.B
4050Einzeldose(n)R03BA0203.04.4.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Pulmicort Turbuhaler 200 authorised in Switzerland?

Yes. Pulmicort Turbuhaler 200 is authorised by Swissmedic under authorisation number 50192, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Pulmicort Turbuhaler 200 have?

Pulmicort Turbuhaler 200 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Pulmicort Turbuhaler 200?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com